Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | JAK2 |
Variant | E386* |
Impact List | nonsense |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | JAK2 E386* results in a premature truncation of the Jak2 protein at amino acid 386 of 1132 (UniProt.org). Due to the loss of the protein kinase domains (UniProt.org), E386* is predicted to lead to a loss of Jak2 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
JAK2 mutant JAK2 inact mut JAK2 E386* |
Transcript | NM_004972.4 |
gDNA | chr9:g.5064982G>T |
cDNA | c.1156G>T |
Protein | p.E386* |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001322195.1 | chr9:g.5064982G>T | c.1156G>T | p.E386* | RefSeq | GRCh38/hg38 |
NM_004972.4 | chr9:g.5064982G>T | c.1156G>T | p.E386* | RefSeq | GRCh38/hg38 |
NM_001322195 | chr9:g.5064982G>T | c.1156G>T | p.E386* | RefSeq | GRCh38/hg38 |
NM_004972.3 | chr9:g.5064982G>T | c.1156G>T | p.E386* | RefSeq | GRCh38/hg38 |
NM_001322199 | chr9:g.5080620G>T | c.1156G>T | p.E386* | RefSeq | GRCh38/hg38 |
NM_001322199.1 | chr9:g.5080620G>T | c.1156G>T | p.E386* | RefSeq | GRCh38/hg38 |
NM_001322194 | chr9:g.5064982G>T | c.1156G>T | p.E386* | RefSeq | GRCh38/hg38 |
NM_001322195.2 | chr9:g.5064982G>T | c.1156G>T | p.E386* | RefSeq | GRCh38/hg38 |
NM_001322199.2 | chr9:g.5080620G>T | c.1156G>T | p.E386* | RefSeq | GRCh38/hg38 |
NM_001322194.2 | chr9:g.5064982G>T | c.1156G>T | p.E386* | RefSeq | GRCh38/hg38 |
NM_001322196.1 | chr9:g.5064982G>T | c.1156G>T | p.E386* | RefSeq | GRCh38/hg38 |
NM_001322198.1 | chr9:g.5080620G>T | c.1156G>T | p.E386* | RefSeq | GRCh38/hg38 |
NM_004972 | chr9:g.5064982G>T | c.1156G>T | p.E386* | RefSeq | GRCh38/hg38 |
NM_001322198.2 | chr9:g.5080620G>T | c.1156G>T | p.E386* | RefSeq | GRCh38/hg38 |
NM_001322196.2 | chr9:g.5064982G>T | c.1156G>T | p.E386* | RefSeq | GRCh38/hg38 |
NM_001322196 | chr9:g.5064982G>T | c.1156G>T | p.E386* | RefSeq | GRCh38/hg38 |
NM_001322194.1 | chr9:g.5064982G>T | c.1156G>T | p.E386* | RefSeq | GRCh38/hg38 |
NM_001322198 | chr9:g.5080620G>T | c.1156G>T | p.E386* | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|